Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 40 results for "habil khorakiwala"

No scope of US intervention in Indian pharma cos: Wockhardt

Wockhardt chief Habil Khorakiwala says that Indian generic company as a whole is a competitive industry in US and therefore there is no scope for government intervention there. Anmol Ganjoo of JM Financial says if drug prices come down then Indian pharma ... Money Control, 1 week ago
Wockhardt hits 52-week low Business Standard India, 2 months ago

3 images for "habil khorakiwala"

Deccan Chronicle, 2 weeks ago
Orissadiary.com, 2 months ago
Siasat Daily, 5 months ago
OrissaDiary

USFDA issues warning letter to Wockhardt's Ankleshwar plant

Wockhardt chairman Habil Khorakiwala The US Food and Drug Administration (USFDA) has issued a warning letter to Wockhardt for violating current good manufacturing practice norms, including its failure to ensure proper clothing for workers at its ...
 Smart Investor2 weeks ago KIIT University confers D. Litt. upon Dr. Habil Khorakiwala, Founder Chairman, Wockhardt Group  OrissaDiary2 months ago FDA Issues Warning Letter To Wockhardt???s Ankleshwar Plant  BioSpace1 week ago Wockhardt's Ankleshwar unit gets EU good manufacturing certificate  The Freepress Journal2 weeks ago
[x]  
Indian Express

India needs more human efforts for excellence in science & research: CNR Rao

"India has to put much more human efforts in science research. Greatness does not come by taking life easy, it comes by hard work," he said. Lamenting that few Indian universities and institutes find a place in global ranking of institutions of ...
 Indian Express6 days ago

Sensex, Nifty consolidate; Capital Goods, IT indices rally

NTPC, L&T, Infosys, ONGC and ICICI Bank are top gainers while Lupin, Dr Reddy's Labs, Coal India, Sun Pharma and BHEL are losers in the Sensex. 13:00 Moneycontrol Bureau 1:45 pm European market: Bourses in Europe opened lower after President-elect ...
 Moneycontrol.com1 week ago

Nifty hovers around 8400, Sensex firm; NTPC, Power Grid surge

Benchmark indices maintained uptrend amid volatility in noon trade but broader markets continued to underperform. Banks, infra and select technology stocks gained while the selling continued in FMCG, healthcare and HDFC group stocks. 12:00 ...
 Moneycontrol.com1 week ago
Financial Express

Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8,400

In the afternoon trade, BSE Sensex rose 114.19 points to 27,254.6, while NSE Nifty was up 28.9 points at 8,409.55, crossing the 8,400-mark for the first time since November 11. Pharmaceutical shares extended losses continued to limit the gains in ...
 Financial Express1 week ago
Ani News

Jaitley releases 'Economy of Jobs' at FICCI's 89th AGM

15:21 IST New Delhi [India], Dec.17 ( ANI ): The need for creating jobs and work opportunities for Indian youth is imperative in view of the country's demographic profile.The task is highly challenging, especially when technology is increasingly ...
 Ani News1 month ago
Money Control

Pharma sector sales down 10-12%, pain to ease by Jan: Wockhardt

The pharmaceutical industry did suffer some set back with sales declining about 10-12 percent since demonetisation. However, Habil F Khorakiwala, Founder, Chairman Group CEO of Wockhardt feels the impact will last only until January at the most as cash ...
 Money Control1 month ago

YK Hamied: Cipla's fearless crusader

Image: Vikas Khot In 2000-01, the HIV/Aids threat had intensified across sub-Saharan Africa, affecting millions. To compound the problem, the medicines that could help treat the condition were prohibitively priced, making them unaffordable for the ...
 Forbes India1 month ago

Sensex, Nifty Extend Gains To Day 2 As Capital Goods Shares Rebound

Wockhardt Shares Fall After FDA Warning Letter on U.K. Factory The healthcare firm's shares fell as much as 4.7 percent after the Food and Drug Administration issued a warning letter against a U.K. subsidiary's drug manufacturing facility, and ...
 Bloomberg-Quint1 month ago Wockhardt Shares Fall After FDA Warning Letter on U.K. Factory  Bloomberg1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less